Joint meeting with: Diabetes: Many Faces of the Disease
Obesity: From Cell to Patient
February 1-3, 2021 | 10:00AM EST | 3:00PM UTC*
*Program is in development and subject to change
Attention
The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.
Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries
Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.
Obesity is a chronic disease affecting millions of people world-wide, and is often associated with numerous co-morbidities, including Type II diabetes, liver disease and cardiovascular disease. This conference aims to gather the world leaders in obesity research and discuss numerous topics- from the cell to the patient- as they relate to obesity. Obesity is an annual topic for Keystone Symposia and is considered to be one of the most critical in the field and the previous Keystone Symposia conferences have been heavily focused on basic research. Therefore, this conference program particularly aims to address this gap by providing a greater balance with clinical/translational research on the program. Additionally, there are sessions that have a special focus on the gut/brain axis, including the microbiota, as there is emerging research in this area that has made transformational steps in our understanding of etiology of this disease, as well as in treatment. Moreover, there is strong evidence that the gut/brain axis is important not just for appetitive behavior but also energy homeostasis, blood glucose and even emotional state. Finally, this conference is being held jointly with the annual diabetes conference, Diabetes: Many Faces of the Disease, as there is obvious overlap in these fields. Therefore, the program will contain joint sessions and even a joint Keynote speaker. With this pairing, it is anticipated to draw the leaders in this field from around the world, as well as the next generation of future scientists. Connecting scientists in basic, transitional, clinical and pharmaceutical research will be crucial to moving the field forward.
Pricing:
Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD
Deadlines:
Abstract Submission:
‣ For Short Talk Consideration: Passed
‣ For Poster Booth: Passed
ePoster / SciTalk Submission: January 22, 2021
Financial Aid Application: Passed
*Please note, abstract submission is required
in order to submit an ePoster and/or Scitalk
#VKSObesity21
Keynote Speaker
Morris F. White, PhD
Boston Children's Hospital, Harvard Medical School
Speaking at this eSymposia
Rachel L. Batterham
University College London, UK
Hans Rudolf Berthoud
Pennington Biomedical Research Center, USA
Diego V. Bohórquez
Duke University Medical Center, USA
Michael A. Cowley
Monash University, Australia
Ana Domingos
University of Oxford, UK
Carmella Evans-Molina
Indiana University, USA
Stephanie E. Fulton
University of Montreal, Canada
Carla J. Greenbaum
Benaroya Research Institute at Virginia Mason, USA
Sean M. Hartig
Baylor College of Medicine, USA
Shane T. Hentges
Colorado State University, USA
Alka M. Kanaya
University of California, San Francisco, USA
Lotte Bjerre Knudsen
Novo Nordisk A/S, Denmark
Michael Krashes
NIDDK, National Institutes of Health, USA
Rory J. McCrimmon
University of Dundee, UK
Martin G. Myers Jr.
University of Michigan, USA
Max Nieuwdorp
University of Amsterdam, Netherlands
Mary-Elizabeth Patti
Joslin Diabetes Center, USA
Linda Rinaman
Florida State University, USA
Darleen A. Sandoval
University of Colorado, USA
Camilla Charlotte Schéele
University of Copenhagen, Denmark
Philipp E. Scherer
University of Texas Southwestern Medical Center, USA
Gary J. Schwartz
Albert Einstein College of Medicine, USA
Michael W. Schwartz
University of Washington, USA
Dana M. Small
Yale University School of Medicine, USA
Elinor L. Sullivan
Oregon National Primate Research Center, USA
Roy Taylor
Newcastle University, UK
Murielle M. Veniant
Amgen Inc., USA
Stephanie Wesolowski
University of Colorado Denver, USA
Morris F. White
Boston Children's Hospital, Harvard Medical School, USA
Lori M. Zeltser
Columbia University, USA
This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
Donate to Keystone Symposia
